J
Julie Swann
Researcher at North Carolina State University
Publications - 179
Citations - 3163
Julie Swann is an academic researcher from North Carolina State University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 24, co-authored 163 publications receiving 2720 citations. Previous affiliations of Julie Swann include Georgia Institute of Technology.
Papers
More filters
Book ChapterDOI
Coordination of Pricing and Inventory Decisions: A Survey and Classification
TL;DR: In this paper, the authors explore innovative pricing strategies in an effort to improve their operations and ultimately the bottom line, including potential increases in profit, and improvements such as reduction in demand or production variability, resulting in more efficient supply chains.
Journal ArticleDOI
Simple Procedures for Selecting the Best Simulated System When the Number of Alternatives is Large
TL;DR: The approach is to use the data provided by the first stage of sampling in an R&S procedure to screen out alternatives that are not competitive, and thereby avoid the (typically much larger) second stage sample for these systems.
Journal ArticleDOI
Estimating Rates of New Root Caries in Older Adults
TL;DR: It is suggested that older adults experience high rates of new caries and could benefit from caries-prevention programs and should be interpreted with caution.
Journal ArticleDOI
Improving Humanitarian Operations through Technology-Enabled Collaboration
TL;DR: In this article, the use of an IT tool to improve last-mile supply distribution and data management in one of many camps for internally displaced persons after the January 2010 earthquake in Haiti, and other current uses of technology in camp management.
Journal ArticleDOI
Evaluation of Telemedicine for Screening of Diabetic Retinopathy in the Veterans Health Administration
Eser Kirkizlar,Nicoleta Serban,Jennifer A. Sisson,Julie Swann,Claire S Barnes,Michael D. Williams +5 more
TL;DR: It is not cost-effective to screen patients aged older than 80 years or in populations with <3500 patients, and future screening policies should give consideration to the age of patients receiving screenings and the system's patient pool size.